1. Home
  2. AXGN vs ECPG Comparison

AXGN vs ECPG Comparison

Compare AXGN & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • ECPG
  • Stock Information
  • Founded
  • AXGN N/A
  • ECPG 1998
  • Country
  • AXGN United States
  • ECPG United States
  • Employees
  • AXGN N/A
  • ECPG N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ECPG Finance Companies
  • Sector
  • AXGN Health Care
  • ECPG Finance
  • Exchange
  • AXGN Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • AXGN 789.6M
  • ECPG 905.2M
  • IPO Year
  • AXGN N/A
  • ECPG 1999
  • Fundamental
  • Price
  • AXGN $16.44
  • ECPG $43.24
  • Analyst Decision
  • AXGN Strong Buy
  • ECPG Strong Buy
  • Analyst Count
  • AXGN 6
  • ECPG 3
  • Target Price
  • AXGN $25.83
  • ECPG $62.67
  • AVG Volume (30 Days)
  • AXGN 908.7K
  • ECPG 317.6K
  • Earning Date
  • AXGN 11-06-2025
  • ECPG 11-05-2025
  • Dividend Yield
  • AXGN N/A
  • ECPG N/A
  • EPS Growth
  • AXGN N/A
  • ECPG N/A
  • EPS
  • AXGN N/A
  • ECPG N/A
  • Revenue
  • AXGN $203,271,000.00
  • ECPG $1,467,587,000.00
  • Revenue This Year
  • AXGN $19.65
  • ECPG $27.55
  • Revenue Next Year
  • AXGN $15.84
  • ECPG $5.84
  • P/E Ratio
  • AXGN N/A
  • ECPG N/A
  • Revenue Growth
  • AXGN 17.17
  • ECPG 15.50
  • 52 Week Low
  • AXGN $9.22
  • ECPG $26.45
  • 52 Week High
  • AXGN $21.00
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 47.29
  • ECPG 53.61
  • Support Level
  • AXGN $17.01
  • ECPG $40.48
  • Resistance Level
  • AXGN $18.64
  • ECPG $42.20
  • Average True Range (ATR)
  • AXGN 0.71
  • ECPG 1.39
  • MACD
  • AXGN -0.18
  • ECPG -0.23
  • Stochastic Oscillator
  • AXGN 0.48
  • ECPG 42.81

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.

Share on Social Networks: